Pharmaceutical Regulatory Services
Technical Writing
Medical Writing
RIMS Management
Data Governance & Regulatory Compliance
Regulatory Affairs Consulting
Regulatory Intelligence
Solving Biggest Challenges for Pharmaceutical Clients
Lack of specialized in-house resources
Challenge
Our SMEs provide value that cannot be achieved internally without huge investment in resources.
Our Approach
Complexity of global standards
and requirements
Challenge
Our technology enables us to adhere to complex region-specific requirement and maintain quality consistency.
Our Approach
Tight deadlines
Challenge
Where other providers struggle, we’re able to meet the toughest deadline. Our in-house Ai, automtion and template solutions relieve delivery teams from repetitive, time-consuming tasks.
Our Approach
Quality control
Challenge
Data is formatted, maintained, and secured thought out tech solutions, minimizing human error and improving data quality.
Our Approach
Regulatory Pharma Services for All Product Lifecycle Stages
Small Molecules
Biologics
Generics
Advanced Therapies
Biosimilars
Combination Products
CAPTIS® AI and Automation Technology
In-house AI-powered regulatory compliance technology, designed to streamline medical writing and documentation processes. CAPTIS® AI platform reduces manual effort, enhances regulatory accuracy, and creates effortless experiences for Celegence project teams and our customers.
eCTD viewer and dossier management
Our proprietary cloud-based dossier management solution eliminates manual steps in the exchange of regulatory dossiers. It allows you to share, view, and review eCTD, NeeS, and other dossier formats from any region and access them in any location with highest level of data protection.
eCTD-Ready Templates
Intuitive MS Word templates for eCTD-ready documents without software installation include stand-alone regulatory documents for, amongst others, NDA/BLA, IND, NDS, MAA, CTA, PIP, scientific advice, and briefing packages.
Celegence in-house technology for pharmaceutical support
-
50%
Faster delivery with intact quality
-
>95%
Improved accuracy over manual processes
-
30%
In saving against current operational cost
SME-DRIVEN EXPERTISE
- All our project leads have a Master's degree in a relevant field
- All have 10+ years of experience in Pharmaceutical Regulatory domain
- Experienced supporting regulatory strategy in 50+ countries
Based in the Netherlands, Maurice has over 27 years’ experience in the pharmaceutical and biotech industry, mainly supporting pre-approval drugs and biologics for oncology, pulmonary and cardiovascular indications, with extensive experience in developing regulatory strategies, leading cross-functional teams in health authority interactions (Scientific Advice, both on national and EU level) regulatory intelligence and applications including document development to support applications such as MAAs, CTAs, EU & US Orphan Drug Applications, PIPs, iPSPs, IND Annual Reports and DSURs. He holds a Master’s degree in Medical Biology from the University of Utrecht and a Doctorate in Medicines from the University of Leiden, Netherlands. Fastest EU MAA approval for a monoclonal antibody in an ultra-orphan (at the time). Successfully guided a client through the PIP application process in 9 months (average is 18).
He holds a Master’s degree in Medical Biology from the University of Utrecht and a Doctorate in Medicines from the University of Leiden, Netherlands.
Fastest EU MAA approval for a monoclonal antibody in an ultra-orphan (at the time). Successfully guided a client through the PIP application process in 9 months (average is 18).
Read More
Read Less
With 20+ years of Pharmaceutical industry experience across Drug Discovery, Regulatory Affairs, and Compliance, Pradeep is a system and business process owner leading our Pharma division delivery teams. Pradeep holds a Master's degree in Biotechnology from Bangalore University.
- Established a Regulatory Operations team for Consumer Health business unit
- Spearheaded several RIM/eDMS and publishing system migrations
- Successfully managed xEVMPD integration into P&G Healthcare business unit
- Led business process harmonization and digitization activities for raw materials documentation and its compliance
- Co-chaired IDMP office
Read More
Read Less
Maikel Bouman is our Associate Director of Regulatory Operations and Publishing, with 8 years of industry experience.
He has broad subject matter expertise on the quality control of data, document publishing, planning/coordination, management, preparation/creation, and dispatch of different types of electronic submission formats to various regulatory authorities across the Americas, Europe and Australia.
Read More
Read Less
As a manager within Regulatory Data Management at Celegence, John has extensive experience in xEVMPD, IDMP, RIMS, and Regulatory Affairs.
John has supported numerous pharmaceutical companies in their digital transformations by selecting the right regulatory information management system, extracting & remediating regulatory data, reviewing and updating underlying processes, and fostering a culture of collaboration and innovation among teams to drive successful change.
Read More
Read Less
resources
Pharmaceutical
Navigating Regulatory Challenges for Generic Inhalation Drug Products: A Strategic Approach
27 Mar, 2025
Pharmaceutical
Understanding the Critical Role of CMC Dossiers in Pharmaceutical Regulatory Submissions
24 Feb, 2025
Pharmaceutical
Overcoming Regulatory Challenges for Cell and Gene Therapy Products: Insights into ATMP Success
30 Jan, 2025
Pharmaceutical
Efficiency in Regulatory Submissions with Lean Authoring: Save Time, Improve Compliance, and Streamline Global Regulatory Documentation Processes
17 Jan, 2025
Pharmaceutical
Ensuring Drug Product Integrity: Key Considerations from FDA’s Draft Guidance on 21 CFR 211.110
07 Jan, 2025
Pharmaceutical
Regulatory Submissions, Information, and Document Management Forum (RSIDMF) 2025
06 Jan, 2025
Pharmaceutical
Pharmaceutical Focus Group Shares Best Practices in Regulatory Publishing and Submissions
28 Nov, 2024
Pharmaceutical
Ad/Promo Submissions to the FDA: Process, Transition, and Compliance with eCTD
12 Nov, 2024
Pharmaceutical
Centre of Excellence Model to Streamline Nonclinical Data Processing and Presentation in Contributor Reports
25 Mar, 2025
Pharmaceutical
Publishing Center of Excellence in the EU, US, Japan & China for a Global Pharmaceutical Company
25 Mar, 2025
Pharmaceutical
EU MDR Template Creation for a Global Multinational Life Sciences Manufacturer
25 Mar, 2025
Pharmaceutical
Multi-year Partnership for CCDS (Core Company Data Sheet) Creation and Updates
25 Mar, 2025
Pharmaceutical
Celegence Deploys Centre of Excellence Model to Streamline Regulatory Activities
25 Mar, 2025
Pharmaceutical
Regulatory affairs support, Publishing & Submissions and Solutions for a young pharmaceutical company
25 Mar, 2025
Pharmaceutical
Regulatory and Market Intelligence Support for a Top-Tier Biotechnology Firm
25 Mar, 2025
Pharmaceutical
Implementation of Veeva Vault IDMP Functionality for a Global Pharmaceutical Company
25 Mar, 2025
The Burden of Brexit on the Medtech Industry: Whitepaper
The Burden of Brexit on the Medtech Industry: Whitepaper Make sure your organization is well versed and prepared for the implications of Brexit by reading Celegence’s White Paper examining the challenges and implications of compliance in the United Kingdom following Brexit.
EU Scientific Advice Whitepaper
Download our exclusive report to streamline regulatory approvals and optimize your EU scientific advice strategy.
Lean Authoring Checklist
Lean Authoring: Eliminating Redundancies And Complexities For The Pharmaceutical Industry And Health Authorities
Regulatory Readiness and Resources Survey Report 2024
Get instant access to the survey report that regulatory professionals are talking about: the 2024 RAPS & Celegence Regulatory & Readiness Survey.
Austria
Austrian Agency for Health and Food Safety (AGES)
Belgium
Federal Agency for Medicines and Health Products (FAGG)
Bulgaria
Bulgarian Drug Agency (BDA)
Croatia
Agency for medicinal products and medical devices of Croatia (HALMED)
Cyprus
Ministry of Health – Pharmaceutical Services
Czech Republic
State Institute for Drug Control (SUKL)
Denmark
Danish Medicines Agency (DKMA)
Estonia
State Agency of Medicines (Ravimiamet)
Finland
Finnish Medicines Agency (FIMEA)
France
National Agency for the Safety of Medicine and Health Products (ANSM)
Germany
German Institute of Medical Documentation and Information
Hungary
National Institute of Pharmacy and Nutrition (OGYEI)
Iceland
Icelandic Medicines Agency (IMA)
Ireland
Health Products Regulatory Authority (HPRA)
Italy
Italian Medicines Agency (AIFA)
Latvia
State Agency of Medicines of the Republic of Latvia
Liechtenstein
Office of Health / Department of Pharmaceuticals
Lithunia
State Medicines Control Agency (VVKT)
Luxembourg
Ministry of Health
Malta
Malta Medicines Authority
Australia
Austria
Belgium
Bulgaria
Canada
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Japan
Latvia
February 3, 2025 | North Bethesda, MD
Regulatory Submissions, Information, and Document Management Forum (RSIDMF) 2025
September 19, 2024 | Berlin, Germany
10th Annual Master Data and Data Governance Excellence in Life Sciences – September 2024
April 10, 2025 | Baltimore, Maryland
6th Annual Life Science Regulatory Intelligence & Strategy Conference
April 28, 2025 | Berlin, Germany